Scholars Central

Conference abstractPublished 31 Mar 2017

Different structure-oriented design of selective butyrylcholinesterase probe and its application in drug discovery

Authors: Wen-Chao Yang, Shu-Hou Yang, Qi Sun, Guang-Fu Yang

Central China Normal University, China

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The two major human cholinesterases are acetylcholinesterase (AChE; EC 3.1.1.7) and butyrylcholinesterase (BChE; EC 3.1.1.8), and are very important enzymes in multiple areas such as pharmacology, neurobiology and toxicology due to their significant roles in human body and health. Although the biological function is uncertain, the BChE levels have been implicated in lipid metabolism and various human diseases such as liver damage, cirrhosis, AlzheimerâÂ?Â?s disease (AD) and liver metastasis. BChE is also responsible for detoxifying xenobiotics like organophosphates and cocaine and is a well-known biomarker for clinical diagnosis. Thus, the quantification of BChE activity and its inhibition is not only important in diseases diagnosis, but also indispensable for drug discovery. We report on the different structure-oriented design and application of a selective fluorogenic molecular probe (BChEFP) for human butyrylcholinesterase (BChE). This probe, rationally designed by mimicking the native substrate and manipulating the steric feature of the recognition group of designed probes targeting the structural difference of the active sites for BChE and acetylcholinesterase (AChE), exhibits near-zero background fluorescence but produce remarkable fluorescence enhancement upon the catalysis by BChE in a fast biochemical reaction. To the best of our knowledge, BChE-FP is the first probe that can discriminate BChE from AChE, which is successfully applied for BChE inhibitor screening and characterization under physiological conditions, and BChE detection in human serum. These results demonstrate that this molecular probe can function as a useful molecular tool for high-throughput drug discovery against BChE-related diseases, as well as the biosensing for neuromuscular blocking agents.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Biotechnology & Biomaterials.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Biotechnology & Biomaterials
  • SubjectBiochemistry & Biotechnology
  • SubjectMaterials Science
  • BylineArticles whose byline prints “Wen-Chao Yang”
  • BylineArticles whose byline prints “Shu-Hou Yang”
  • BylineArticles whose byline prints “Qi Sun”
  • BylineArticles whose byline prints “Guang-Fu Yang”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels